DEEPA KARUNAKARAN: Open Payments
NPI 1508485434 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $180 |
| Tandem Diabetes Care, Inc. | 3 | $57 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Korlym, t:slim X2 Insulin Pump with Control-IQ, ISTURISA, JARDIANCE, GVOKE HYPOPEN, STRENSIQ, EVENITY, Kerendia.
Industry payments across TX — which companies pay providers there.
